OEP

Corporate Operation Organizational Chart

Board of Directors
The 15th Board of Directors consists of 7 directors (including 2 independent directors) and 3 supervisors. All serve for three-year terms. The term of office of the current Board of Directors is from June 3, 2016 to June 2, 2019.

Chairman Peter Tsai	Bachelor of Chinese Literature, Soochow University Chairman, Orient EuroPharma Co., Ltd.
Director Jack Wu	Bachelor of Science in Pharmacy, Taipei Medical University General Manager of Nutricare BU, Orient EuroPharma Co., Ltd.
Director Sylin Ltd. (Bermuda) Representative: Peter Wang	EMBA, National Taiwan University President, Wyeth (US) / Taiwan Wyeth
Director Sylin Ltd. (Bermuda) Representative: Chi-Chow Liao	St. John’s University Industrial Pharmacy Ph. D General Manager, Medical and Pharmaceutical Industry Technology and Development Center Director of Pharmaceutical Affairs, Taiwan Food and Drug Administration
Director Calvin Tsai	Accounting, University of California. Riverside, USA General Manager, Orient EuroPharma Co., Ltd.
Independent Director Hwa-Min, Lin	Master of Business Administration, Keio University, Japan Chairman and General Manager, IFCT Consulting Co., Ltd.
Independent Director Praveen Tyle	President & CEO, Osmotica Pharmaceutical corporation, USA

Supervisor

Independent Supervisor

Richard Yang

Master of Accounting, Soochow University
CPA, Richard Yang and Co.

Supervisor

Taiwan Excelsior Co., Ltd.

Representative: Chin-Hsin Hsu

LL.M.,Northwestern University, USA
Judge, Taiwan Keelung District Court
Associate partner, Formosa Transnational Attorneys at Law
CLO, Mercuries & Associates, Ltd.

Supervisor

Cynthia Lin

Bachelor of Commerce, National Taiwan University
Director, Taiwan Excelsior Co., Ltd.

Diversity of Board Members

Name	Gender	Ability to make operational judgement	Ability to perform accounting and financial analysis	Ability to conduct management administration	Ability to conduct crisis management	Knowledge of the industry	International market perspective	Ability to lead	Ability to make policy decisions
bar
Peter Tsai	Male
Jack Wu	Male
Peter Wang	Male
Chi-Chow Liao	Male
Calvin Tsai	Male
Hwa-Min Lin	Male
Praveen Tyle	Male
Richard Yang	Male
Chin-Hsin Hsu	Female
Cynthia Lin	Female

Remuneration Committee
The 3rd Remuneration Committee consists of 3 members. The term of current Remuneration Committee members is from June 3, 2016 to June 2, 2019, the same as that of the board of directors by whom they were appointed.

Hwa-Min, Lin	Master of Business Administration, Keio University, Japan Independent Director, Orient EuroPharma Co., Ltd. Independent Director, Orient Pharma Co., Ltd. Independent Director, Redhorse Corporation Chairman and General Manager, IFCT Consulting Co., Ltd. Director, Taiwan Private Equity Association
Kathy Yang	MBA, Human Resources Management, National Central University Vice President, ABB Ltd. Director & Principal Consultant, Willis Towers Watson HR Director, ISS Facility Services Taiwan Ltd. HR Director, NXP Semiconductors Taiwan Ltd. HR Director, ZT Systems
Amy Huang	Biochemistry Ph.D. Program, Rutgers State university of New Jersey, USA BS of Chemistry, National Tsing Hua university, Taiwan Vice President, Taian Technologies Corp. General Manager, Maxpro Venture Independent Director, Orient Pharma Co., Ltd. Board of Director, Topmunnity Therapeutics Ltd.

Articles of Incorporation and Regulations

Elaboration on Internal Auditing Organization and Operation

Purpose of Internal Audit

The purpose of setting up internal audits at OEP is to examine and evaluate the validity of internal control systems, measure operational efficiency and compliance with applicable laws, and provide improvement suggestions whenever needed so as to ensure the continuous effective implementation of internal control.

Internal Auditor Setup

Our company has one internal auditor who is directly responsible to the Board of Directors.

Operation of Internal Audits

1. Scope of Audit:

Internal auditing works include inspecting and evaluating the adequacy and validity of the internal control systems of the company’s departments as well as performance in business activities.

2. Target of Audit:

Targets include all business activities that are responsible by all units of the company and associated branches.

3. Method of Audit:

In principle, auditors should conduct onsite auditing on the unit under audit and may ask the unit under audit to provide documents, accounting books, certificates, and other printed information for auditing.

4. Internal Audit Operating Procedures:

Audit works include audit planning, information inspection and assessment, result communication, and follow-up reviews.
Annual audit plans should be based on risk assessments. Audit procedures should be established for individual cases and compiled into work sheets.
At the end of an onsite audit, audit results must be fully communicated to the head of the unit under audit. When necessary, improvement plans and expected date of completion for the unit under audit should be obtained, and auditors should track any actions of improvements.

5. Submission of Audit Report:

Auditors should truthfully disclose errors and irregularities identified during inspection in audit reports, and
conduct follow-up on these findings and produce them into a follow-up report.

Corporate Governance

Articles of Incorporation and Regulations

Elaboration on Internal Auditing Organization and Operation